Skip to content

Exploring Semi-Quantitative Pregnancy Tests and Their Impact on Reproductive Health Service Provision

Exploring Semi-Quantitative Pregnancy Tests and Their Impact on Reproductive Health Service Provision

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00812890
Enrollment
400
Registered
2008-12-22
Start date
2008-11-30
Completion date
2009-09-30
Last updated
2011-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

This study will examine the feasibility, practicality, utility and usability of a semi-quantitative urine pregnancy test (dBest One Step hCG Panel Test Kit) recently approved by the food and drug administration (FDA) for both Professional (physician office) and over-the-counter (consumer) use. The study seeks to: 1. Assess the correlation of this pregnancy test results with serum values (as distinct from urine) hCG. 2. Assess whether or not time of day of urine collection has any impact on the outcome of the dBest test. 3. Assess user comprehension of the pregnancy test, especially assessment of the result.

Detailed description

This study will examine the feasibility, practicality, utility and usability of a semi-quantitative urine pregnancy test (dBest One Step hCG Panel Test Kit) recently approved by the food and drug administration (FDA) for both Professional (physician office) and over-the-counter (consumer) use. The study seeks to: 1. Assess the correlation of this pregnancy test results with serum values (as distinct from urine) hCG. 2. Assess whether or not time of day of urine collection has any impact on the outcome of the dBest test. 3. Assess user comprehension of the pregnancy test, especially assessment of the result.

Interventions

Sponsors

Gynuity Health Projects
CollaboratorOTHER
Stanford University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women 18 years or older, presenting for early abortion, pre-natal care, or fertility services. * If pregnant, gestational age \< 84 days by LMP, ultrasound or clinical assessment. * Agrees to return for follow-up visit and willing to provide an address and/or telephone number for purposes of follow-up. * Able to consent to study participation.

Exclusion criteria

* Women less than 18 years of age. * Women who are not pregnant, except if presenting for IVF services.

Design outcomes

Primary

MeasureTime frame
To assess the correlation between this pregnancy test's results with serum values (as distinct from urine) hCG. 2. To assess whether or not urine concentration has any impact on the outcome15 minutes pregnancy test reading

Secondary

MeasureTime frame
To assess user comprehension of the test.study duration

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026